Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. BAGNIS C; DERAY G; DUBOIS M; PIROTZKY E; JACQUIAUD C; BAGHOS W; AUPETIT B; BRAQUET P; JACOBS C
   PREVENTION OF CYCLOSPORINE NEPHROTOXICITY WITH A PLATELET-ACTIVATING-FACTOR (PAF) ANTAGONIST
   Nephrology, dialysis, transplantation
   
   C. Bagnis et al., "PREVENTION OF CYCLOSPORINE NEPHROTOXICITY WITH A PLATELET-ACTIVATING-FACTOR (PAF) ANTAGONIST", Nephrology, dialysis, transplantation, 11(3), 1996, pp. 507-513
2. LETEXIER L; FAVRE E; REDEUILH C; BLAVET N; BELLAHSENE T; DIVE G; PIROTZKY E; GODFROID JJ
   STRUCTURE-ACTIVITY-RELATIONSHIPS IN PLATELET-ACTIVATING-FACTOR (PAF) .7. TETRAHYDROFURAN DERIVATIVES AS DUAL PAF ANTAGONISTS AND ACETYLCHOLINESTERASE INHIBITORS - SYNTHESIS AND PAF-ANTAGONISTIC ACTIVITY
   Journal of lipid mediators and cell signalling
   
   L. Letexier et al., "STRUCTURE-ACTIVITY-RELATIONSHIPS IN PLATELET-ACTIVATING-FACTOR (PAF) .7. TETRAHYDROFURAN DERIVATIVES AS DUAL PAF ANTAGONISTS AND ACETYLCHOLINESTERASE INHIBITORS - SYNTHESIS AND PAF-ANTAGONISTIC ACTIVITY", Journal of lipid mediators and cell signalling, 13(3), 1996, pp. 189-205
3. LETEXIER L; FAVRE E; RONZANI N; MASSICOT F; BLAVET N; PIROTZKY E; GODFROID JJ
   STRUCTURE-ACTIVITY-RELATIONSHIPS IN PLATELET-ACTIVATING-FACTOR (PAF) .8. TETRAHYDROFURAN DERIVATIVES AS DUAL PAF ANTAGONISTS AND ACETYLCHOLINESTERASE INHIBITORS - ANTIACETYLCHOLINESTERASE ACTIVITY AND COMPARATIVE SAR
   Journal of lipid mediators and cell signalling
   
   L. Letexier et al., "STRUCTURE-ACTIVITY-RELATIONSHIPS IN PLATELET-ACTIVATING-FACTOR (PAF) .8. TETRAHYDROFURAN DERIVATIVES AS DUAL PAF ANTAGONISTS AND ACETYLCHOLINESTERASE INHIBITORS - ANTIACETYLCHOLINESTERASE ACTIVITY AND COMPARATIVE SAR", Journal of lipid mediators and cell signalling, 13(3), 1996, pp. 207-222
4. BUTTERLY DW; SPURNEY RF; RUIZ P; PIROTZKY E; BRAQUET P; COFFMAN TM
   ROLE OF PLATELET-ACTIVATING-FACTOR IN KIDNEY-TRANSPLANT REJECTION IN THE RAT
   Kidney international
   
   D.W. Butterly et al., "ROLE OF PLATELET-ACTIVATING-FACTOR IN KIDNEY-TRANSPLANT REJECTION IN THE RAT", Kidney international, 48(2), 1995, pp. 337-343
5. KOLTAI M; PIROTZKY E; BRAQUET P
   PAF-CYTOKINE AUTOCATALYTIC FEEDBACK NETWORK IN SEPTIC SHOCK - INVOLVEMENT IN ACUTE-RENAL-FAILURE
   Nephrology, dialysis, transplantation
   
   M. Koltai et al., "PAF-CYTOKINE AUTOCATALYTIC FEEDBACK NETWORK IN SEPTIC SHOCK - INVOLVEMENT IN ACUTE-RENAL-FAILURE", Nephrology, dialysis, transplantation, 9, 1994, pp. 69-72
6. SPINNEWYN B; BLAVET N; PIROTZKY E; BRAQUET P
   PLATELET-ACTIVATING-FACTOR ANTAGONIST, BN-50730, PROTECTS AGAINST THEDEVELOPMENT OF EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS
   Journal of lipid mediators and cell signalling
   
   B. Spinnewyn et al., "PLATELET-ACTIVATING-FACTOR ANTAGONIST, BN-50730, PROTECTS AGAINST THEDEVELOPMENT OF EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS", Journal of lipid mediators and cell signalling, 10(1-2), 1994, pp. 135-137
7. HANSLIK T; BLANCHET F; NOCHY D; PIROTZKY E; GUILMARD C; SETA N; CARBON C
   EFFECT OF THE PLATELET-ACTIVATING-FACTOR ANTAGONIST BN52021 IN RABBITS - ROLE IN GENTAMICIN-NEPHROTOXICITY
   Toxicology and applied pharmacology
   
   T. Hanslik et al., "EFFECT OF THE PLATELET-ACTIVATING-FACTOR ANTAGONIST BN52021 IN RABBITS - ROLE IN GENTAMICIN-NEPHROTOXICITY", Toxicology and applied pharmacology, 128(1), 1994, pp. 111-115
8. ROUBERT P; GILLARDROUBERT V; POURMARIN L; CORNET S; GUILMARD C; PLAS P; PIROTZKY E; CHABRIER PE; BRAQUET P
   ENDOTHELIN RECEPTOR SUBTYPE-A AND SUBTYPE-B ARE UP-REGULATED IN AN EXPERIMENTAL-MODEL OF ACUTE-RENAL-FAILURE
   Molecular pharmacology
   
   P. Roubert et al., "ENDOTHELIN RECEPTOR SUBTYPE-A AND SUBTYPE-B ARE UP-REGULATED IN AN EXPERIMENTAL-MODEL OF ACUTE-RENAL-FAILURE", Molecular pharmacology, 45(2), 1994, pp. 182-188
9. CORNET S; PIROTZKY E; BRAQUET P
   IMPLICATION OF DIFFERENT ENDOTHELIN RECEPTORS IN THE VASCULAR ACTION OF A HYPERTENSIVE DOSE OF ET-1 IN RAT
   Journal of cardiovascular pharmacology
   
   S. Cornet et al., "IMPLICATION OF DIFFERENT ENDOTHELIN RECEPTORS IN THE VASCULAR ACTION OF A HYPERTENSIVE DOSE OF ET-1 IN RAT", Journal of cardiovascular pharmacology, 22, 1993, pp. 190000239-190000292
10. ROUBERT P; CORNET S; PLAS P; GUILMARD C; PIROTZKY E; CHABRIER PE; BRAQUET P
    UP-REGULATION OF RENAL ENDOTHELIN RECEPTORS IN GLYCEROL-INDUCED ACUTE-RENAL-FAILURE IN THE RAT
    Journal of cardiovascular pharmacology
    
    P. Roubert et al., "UP-REGULATION OF RENAL ENDOTHELIN RECEPTORS IN GLYCEROL-INDUCED ACUTE-RENAL-FAILURE IN THE RAT", Journal of cardiovascular pharmacology, 22, 1993, pp. 190000303-190000305
11. VIOSSAT I; DUVERGER D; CHAPELAT M; PIROTZKY E; CHABRIER PE; BRAQUET P
    ELEVATED TISSUE ENDOTHELIN CONTENT DURING FOCAL CEREBRAL-ISCHEMIA IN THE RAT
    Journal of cardiovascular pharmacology
    
    I. Viossat et al., "ELEVATED TISSUE ENDOTHELIN CONTENT DURING FOCAL CEREBRAL-ISCHEMIA IN THE RAT", Journal of cardiovascular pharmacology, 22, 1993, pp. 190000306-190000309